WHY IT MATTERS: Patients using medical cannabis may soon have access to digital tools that help their physicians track symptom changes and adjust treatment more precisely over time. CLINICAL OVERVIEW: The integration of prescription digital therapeutics into cannabinoid medicine represents a meaningful step toward structuring clinical care around measurable outcomes, individualized dosing protocols, and accountable therapeutic frameworks. Digital tools have the potential to capture real-world patient data that traditional clinical encounters often miss, including symptom trajectories, titration responses, and adherence patterns.